Ankur Kumar

发表

Steroid affected cytokines in aspirin‐exacerbated respiratory disease

M. Kohanski, J. Palmer, D. Reed, 2022, International forum of allergy & rhinology.

Age as a factor in treatment of aspirin‐exacerbated respiratory disease: relationship to required aspirin maintenance dose after desensitization

M. Kohanski, J. Palmer, N. Adappa, 2020, International forum of allergy & rhinology.

Major complications of aspirin desensitization and maintenance therapy in aspirin‐exacerbated respiratory disease

M. Kohanski, J. Palmer, N. Adappa, 2020, International forum of allergy & rhinology.

Role of Propofol with total intravenous anesthesia in intra-abdominal surgeries

V. Tyagi, Bilal Ahmad, Ankur Kumar, 2022, International journal of health sciences.

SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD.

N. Adappa, J. Bosso, Heather Ungerer, 2023, Allergy and asthma proceedings.

ANALYSIS OF COMPLICATIONS FOLLOWING ADMINISTRATION OF DIFFERENT DOSES OF NALBUPHINE USED AS ADJUVANT IN PATIENTS UNDERGOING SURGERY UNDER SUB ARACHNOID BLOCK WITH 0.5% HYPERBARIC BUPIVACAINE AT A TERTIARY CARE HOSPITAL

V. Mishra, Akhilesh Mishra, Vivek Kumar, 2023 .

Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease Based on the 12-Item Short Form Survey

J. Palmer, D. Kennedy, N. Adappa, 2021, American journal of rhinology & allergy.

Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease.

J. Palmer, D. Kennedy, N. Adappa, 2021, Allergy and asthma proceedings.

QSAR modeling of chronic rat toxicity of diverse organic chemicals

Kunal Roy, Ankur Kumar, Probir Kumar Ojha, 2023, Computational Toxicology.